Related Experiment Video

Updated: May 10, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Glioma stem cells and immunotherapy for the treatment of malignant gliomas

Masahiro Toda1

  • 1Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

ISRN Oncology
|June 14, 2013
PubMed

Insights

Targeting glioma stem cells (GSCs) and their niche with immunotherapy offers a novel approach for malignant glioma treatment. This review explores GSCs, their niches, and promising immunotherapies for improved patient outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology
  • Immunotherapy

Background:

  • Glioma stem cells (GSCs) are key drivers of malignant glioma, exhibiting resistance to conventional therapies.
  • Complex interactions between GSCs and their microenvironment (niche) influence tumor progression and treatment resistance.

Purpose of the Study:

  • To review recent findings on glioma stem cells and their niches.
  • To discuss the potential of immunotherapy targeting GSCs and their niches for malignant glioma treatment.

Main Methods:

  • Literature review of recent studies on GSCs, their niches, and immunotherapies for glioma.
  • Analysis of preclinical and clinical data on immunotherapy strategies.

Main Results:

  • GSCs and their niche crosstalk is crucial for glioma pathogenesis.
  • Immunotherapy, including peptide vaccines and antibodies, shows promising results in clinical studies.

Conclusions:

  • Targeting both GSCs and their niche is a promising therapeutic strategy.
  • Immunotherapy represents a novel approach with distinct antitumor mechanisms for malignant glioma.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...